SynthesisFrontiers in endocrinology2024

Concurrent neoadjuvant endocrine therapy with chemotherapy in HR+HER2- breast cancer: a systematic review and meta-analysis.

Ping Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.